EQRx, Inc.

EQRx, Inc. (Nasdaq: EQRX) is a biopharmaceutical company that entered the public markets through a business combination with CMLS Holdings Inc., a special purpose acquisition company sponsored by Casdin Capital and Corvina Health Capital that completed its initial public offering in 2020. The August 2021 8-K filing reflects activity surrounding the announcement of the merger agreement that would ultimately bring EQRx onto Nasdaq under the EQRX ticker. The company operates in the healthcare and life sciences sector, with a stated focus on developing and commercializing innovative medicines at substantially reduced prices to expand patient access globally. Sign up at SpacDesk for complete filing histories, deal timelines, and real-time analytics on EQRx and hundreds of other SPAC transactions.